scholarly journals Micronutrient Depletion in Heart Failure: Common, Clinically Relevant and Treatable

2019 ◽  
Vol 20 (22) ◽  
pp. 5627 ◽  
Author(s):  
Natasa Cvetinovic ◽  
Goran Loncar ◽  
Andjelka M. Isakovic ◽  
Stephan von Haehling ◽  
Wolfram Doehner ◽  
...  

Heart failure (HF) is a chronic condition with many imbalances, including nutritional issues. Next to sarcopenia and cachexia which are clinically evident, micronutrient deficiency is also present in HF. It is involved in HF pathophysiology and has prognostic implications. In general, most widely known micronutrients are depleted in HF, which is associated with symptoms and adverse outcomes. Nutritional intake is important but is not the only factor reducing the micronutrient availability for bodily processes, because absorption, distribution, and patient comorbidity may play a major role. In this context, interventional studies with parenteral micronutrient supplementation provide evidence that normalization of micronutrients is associated with improvement in physical performance and quality of life. Outcome studies are underway and should be reported in the following years.

2005 ◽  
Vol 26 (21) ◽  
pp. 2238-2244 ◽  
Author(s):  
Klaus K.A. Witte ◽  
Nikolay P. Nikitin ◽  
Anita C. Parker ◽  
Stephan von Haehling ◽  
Hans-Dieter Volk ◽  
...  

Author(s):  
Balabanov A.S. ◽  
Tupitsyn V.V. ◽  
Trinh Van Nhan

Relevance. Problems of chronic heart failure (HF) after myocardial infarction (MI) prevention of in young and middle-aged men with chronic inflammatory pulmonary diseases (CIPD) remain relevant due to their high prevalence and social significance. Aim. To evaluate changes in the quality of life (QL) indicator associated with heart failure (HF) in men under 60 years old with MI and CIPD to improve prevention and outcomes. Material and methods. The study included men aged 19-60 years old with type I MI. Patients are divided into two age-comparable groups: I - the study group, with CIPD - 166 patients; II - control, without it - 490 patients. A comparative analysis of the QL indicator associated with HF (HFQL) (V. Ironosov) was performed in the selected groups in the first 48 hours (I) and at the end of the third week (II) of MI. The changes and correlations (C. Spearmen) of HFQL with clinical features, metabolic parameters, central and peripheral hemodynamics were studied. Results. HFQL in patients with CIPD was worse than in the control group in both phases of the study (I: 63.6 ± 21.6 and 59.2±20.1; II: 20.7 ± 11.7 and 18.0 ± 12.0, respectively; p˂0.05). Reliable correlations between HFQL and heart rate, blood pressure, parameters of the left ventricle (LV) systolic and diastolic functions, its volume, indicators of the pulmonary circulation, lipid, nitrogen and electrolyte metabolism were revealed. Conclusions. The QL associated with HF is significantly worse in patients with CIPD in the acute and subacute MI periods. The most pronounced negative effect on this indicator in the study group is associated with tachycardia, LV dilatation, its systolic and diastolic dysfunction, pulmonary hypertension, impaired lipid and nitrogen metabolism. The HFQL method is useful as an addition to the complex of examination of patients with MI and MS, starting from the first hours of the disease, for early identification of risk groups for adverse outcomes and the formation of chronic HF.


2021 ◽  
Vol 1 (5(69)) ◽  
pp. 33-37
Author(s):  
V. Lysenko ◽  
V. Syvolap

Chronic heart failure (CHF) remains a major burden due to low quality of life, high morbidity, and mortality. An important aspect in the management of heart failure is to provide clinicians necessary knowledge and resources to make better decisions about treatment tactics of such patients. Thus, finding out independent predictors of adverse outcomes of heart failure is still insufficiently studied, and become an important task of internal medicine and cardiology.


Sign in / Sign up

Export Citation Format

Share Document